 |
|
| TREATMENT OF LEUKEMIA AND LYMPHOMA, 51
| |
| | |
|
|
To order this title, and for more information, click here
By
David Scheinberg, Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.
Joseph Jurcic, Memorial Sloan Kettering Cancer Center, New York, New York, U.S.A.
Included in series
Advances in Pharmacology,
Description
New Treatments of Leukemia and Lymphoma describes the most important advances in the therapy of hematopoietic cancers
that have been derived from recent discoveries in cancer cell biology, kinase biochemistry, and immunology.
Detailed descriptions
of the large number of new and effective agents that have recently become available for the treatment of leukemias and lymphomas as well
as an understanding of their mechanisms of action and their integration into current therapy are provided. A number of experimental
drug reagents currently in clinical investigation are also discussed. The therapies include conventional anti-metabolites, monoclonal
antibodies directed to cell surface receptors, antibodies tagged with toxins and radiopharmaceuticals, inhibitors of specific kinases,
stem cell transplants, and engineered T-cells designed to selectively target hematopoietic cancers.
The contents of the book will
allow practitioners and investigators alike to understand what is current and state of the art as well as what to look for in the future.
Audience
Oncologists, hematologists, cancer researchers, pharmacologists, pharmaceutical and biotechonology company employees
Contents
Kinase Inhibitors in Leukemia
State of the Art Treatment of APL
Investigational Agents in Myeloid Disorders
Methodologic Issues in Investigation
of Targeted Therapies in AML
Purine Analogues in Leukemia
Monoclonal Antibody Therapy in Lymphoid Leukemias
Native Antibody and Antibody-Targeted
Chemotherapy for Acute Myeloid Leukemia
Radioimmunotherapy of Leukemia
Immunotoxins and Toxin Constructs in Leukemia/Lymphoma
Antibody
Therapy of Lymphoma
Vaccines in Leukemia
Therapeutic Idiotype Vaccines for Non-Hodgkin?s Lymphoma
Cytokine Modulation of the Innate
Immune System in the Treatment of Leukemia and Lymphoma
Donor Lymphocyte Infusions
Somatic Cell Engineering and the Immunotherapy
of Leukemias and Lymphomas
| Bibliographic details |
Hardbound, 384 pages, publication date: SEP-2004
ISBN-13: 978-0-12-032952-6
ISBN-10: 0-12-032952-2
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 135.99
USD 225
EUR 160.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company